1 year return (CAGR)
274.74%
Stoke Therapeutics Inc Exchange (NASDAQ, USD)
STOK
27.91
-0.49 (-1.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
49.37%
5 year return (CAGR)
0.30%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.94B
Price/Sales
10.52
Ent value
1.92B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 32.97 |
| Daily high | 32.97 |
| Daily low | 31.77 |
| Daily Volume | 397K |
| All-time high | 69.81 |
| 1y analyst estimate | 46.46 |
| Beta | 1.23 |
| EPS (TTM) | -3.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| STOK | S&P500 | |
| Current price drop from All-time high | -60.02% | -3.06% |
| Highest price drop | -95.17% | -56.47% |
| Date of highest drop | 27 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -62.34% | -10.68% |
| Avg time to new high | 48 days | 12 days |
| Max time to new high | 1332 days | 1805 days |
News
